105 related articles for article (PubMed ID: 7558457)
1. Human chromosome 11 suppresses the tumorigenicity of adenovirus transformed baby rat kidney cells: involvement of the Wilms' tumor 1 gene.
Menke AL; van Ham RC; Sonneveld E; Shvarts A; Stanbridge EJ; Miyagawa K; van der Eb AJ; Jochemsen AG
Int J Cancer; 1995 Sep; 63(1):76-85. PubMed ID: 7558457
[TBL] [Abstract][Full Text] [Related]
2. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
[TBL] [Abstract][Full Text] [Related]
3. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome 11.
Dowdy SF; Fasching CL; Araujo D; Lai KM; Livanos E; Weissman BE; Stanbridge EJ
Science; 1991 Oct; 254(5029):293-5. PubMed ID: 1656527
[TBL] [Abstract][Full Text] [Related]
5. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression.
Weissman BE; Saxon PJ; Pasquale SR; Jones GR; Geiser AG; Stanbridge EJ
Science; 1987 Apr; 236(4798):175-80. PubMed ID: 3031816
[TBL] [Abstract][Full Text] [Related]
6. Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms' tumor assay.
Reid LH; West A; Gioeli DG; Phillips KK; Kelleher KF; Araujo D; Stanbridge EJ; Dowdy SF; Gerhard DS; Weissman BE
Hum Mol Genet; 1996 Feb; 5(2):239-47. PubMed ID: 8824880
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
Cowell JK; Groves N; Baird P
Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
Grundy P; Telzerow P; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
[TBL] [Abstract][Full Text] [Related]
9. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting.
Dao D; Walsh CP; Yuan L; Gorelov D; Feng L; Hensle T; Nisen P; Yamashiro DJ; Bestor TH; Tycko B
Hum Mol Genet; 1999 Jul; 8(7):1337-52. PubMed ID: 10369881
[TBL] [Abstract][Full Text] [Related]
10. A third Wilms' tumor locus on chromosome 16q.
Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
[TBL] [Abstract][Full Text] [Related]
11. Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma.
Dowdy SF; Weissman BE; Stanbridge EJ
J Cell Physiol; 1991 May; 147(2):248-55. PubMed ID: 1645741
[TBL] [Abstract][Full Text] [Related]
12. A nude mouse Wilms' tumor line (KCMC-WT-1) derived from an aniridia patient with monoalleleic partial deletion of chromosome 11p.
Nagashima Y; Nishihira H; Miyagi Y; Tanaka Y; Sasaki Y; Nishi T; Imaizumi K; Aoki I; Misugi K
Cancer; 1996 Feb; 77(4):799-804. PubMed ID: 8616775
[TBL] [Abstract][Full Text] [Related]
13. Beck-Wiedemann syndrome and Wilms' tumour.
Ward A
Mol Hum Reprod; 1997 Feb; 3(2):157-68. PubMed ID: 9239720
[TBL] [Abstract][Full Text] [Related]
14. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of congenital mesoblastic nephroma and its distinction from Wilms tumor.
Tomlinson GE; Argyle JC; Velasco S; Nisen PD
Cancer; 1992 Nov; 70(9):2358-61. PubMed ID: 1327497
[TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.
Satoh Y; Nakadate H; Nakagawachi T; Higashimoto K; Joh K; Masaki Z; Uozumi J; Kaneko Y; Mukai T; Soejima H
Br J Cancer; 2006 Aug; 95(4):541-7. PubMed ID: 16909133
[TBL] [Abstract][Full Text] [Related]
17. Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells.
Fraizer GE; Bowen-Pope DF; Vogel AM
J Cell Physiol; 1987 Oct; 133(1):169-74. PubMed ID: 2444606
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic analysis of chromosome 11p in familial Wilms tumour.
Baird PN; Pritchard J; Cowell JK
Br J Cancer; 1994 Jun; 69(6):1072-7. PubMed ID: 7911030
[TBL] [Abstract][Full Text] [Related]
19. Localization of a putative liver tumor suppressor locus to a 950-kb region of human 11p11.2-p12 using rat liver tumor microcell hybrid cell lines.
Coleman WB; Esch GL; Borchert KM; McCullough KD; Reid LH; Weissman BE; Smith GJ; Grisham JW
Mol Carcinog; 1997 Aug; 19(4):267-72. PubMed ID: 9290704
[TBL] [Abstract][Full Text] [Related]
20. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]